RxDoctor Payments Data

Becky Cooley, PA

Physician Assistant · Sun City, AZNPI 1689627374

Payments from drug & device makers

$713in general payments, 2019–2025

Across 24 payments — averaging $29.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$157
  • Boston Scientific$144
  • Collegium Pharmaceutical, Inc.$140
  • Redhill Biopharma Inc.$67
  • Biodelivery Sciences International, Inc.$67
  • Medtronic$54
  • plus $84 from 5 others

What the payments were for

  • Food & beverage$713100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$713 in reported general payments places this provider in the 60th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$43,223
Medicare patients
117
Services billed
1,802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate44$27,117
MovantikNaloxegol Oxalate30$12,831
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen366$12,155
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen354$8,722
Gabapentin500$8,399
Oxycodone Hcl266$4,714
Naloxone Hcl62$3,571
Tramadol Hcl205$1,968
Morphine Sulfate ErMorphine Sulfate81$1,926
Tizanidine Hcl173$1,893
Cyclobenzaprine Hcl118$1,752
Pregabalin72$1,748
Lidocaine28$1,440
Diclofenac Sodium49$1,322
Baclofen77$1,107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$140$27,11744 claims
Redhill Biopharma Inc.Movantik$67$12,83130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Sun City

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →